Beyond ‘bad’ cholesterol: new clues to the risk of heart disease
Researchers at Chalmers University of Technology, in Sweden, shed new light on the remaining risk of heart disease, even after the known risk factor of
another news portal
Researchers at Chalmers University of Technology, in Sweden, shed new light on the remaining risk of heart disease, even after the known risk factor of
Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD seed financing.
Jo Goldsmith said the RSV vaccine was not available when she was pregnant, but that she would have had it.
Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of
Kelly O’Shea says she’s “lost faith” in women’s health after paying £20k for treatment she needed.
A group of clinicians warns technology use in English schools is driving a rise in health problems like short-sightedness.
Kelly O’Shea says she’s “lost faith” in women’s health after paying £20k for treatment she needed.
Dr Allison Gardner MP has been living with the “searing pain” of recurring infections for a decade.
Medics in Spain raced against time to save Sandra McCartney’s life after her heart stopped beating.
In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined with light-stimulating goggles was generally well
Diseases such as Alzheimer’s and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline.
Are people who have been blind for most of their lives better at hearing than sighted individuals? New in JNeurosci, Woon Ju Park, from Georgia
A new review in Genes & Diseases highlights Piezo channels as important biological links between mechanical forces and the cellular processes that shape the face
Scientists are highlighting long non-coding RNAs (lncRNAs) as promising targets in the effort to overcome one of cancer treatment’s most persistent challenges: therapeutic resistance.